Higher-dose glutathione therapy for Parkinson's disease in Japan: is it really safe?
Identifieur interne : 001977 ( PubMed/Curation ); précédent : 001976; suivant : 001978Higher-dose glutathione therapy for Parkinson's disease in Japan: is it really safe?
Auteurs : Yutaka Naito ; Ko Matsuo ; Yasumasa Kokubo ; Yugo Narita ; Hidekazu TomimotoSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2010.
Descripteurs français
- Wicri :
- geographic : Japon.
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Dose-Response Relationship, Drug, Drug Administration Schedule, Glutathione (administration & dosage), Glutathione (adverse effects), Glutathione (therapeutic use), Humans, Japan, Male, Parkinson Disease (drug therapy).
- MESH :
- chemical , administration & dosage : Antiparkinson Agents, Glutathione.
- chemical , adverse effects : Antiparkinson Agents, Glutathione.
- chemical , therapeutic use : Antiparkinson Agents, Glutathione.
- geographic : Japan.
- drug therapy : Parkinson Disease.
- Aged, Dose-Response Relationship, Drug, Drug Administration Schedule, Humans, Male.
DOI: 10.1002/mds.23022
PubMed: 20131395
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001977
Links to Exploration step
pubmed:20131395Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Higher-dose glutathione therapy for Parkinson's disease in Japan: is it really safe?</title>
<author><name sortKey="Naito, Yutaka" sort="Naito, Yutaka" uniqKey="Naito Y" first="Yutaka" last="Naito">Yutaka Naito</name>
</author>
<author><name sortKey="Matsuo, Ko" sort="Matsuo, Ko" uniqKey="Matsuo K" first="Ko" last="Matsuo">Ko Matsuo</name>
</author>
<author><name sortKey="Kokubo, Yasumasa" sort="Kokubo, Yasumasa" uniqKey="Kokubo Y" first="Yasumasa" last="Kokubo">Yasumasa Kokubo</name>
</author>
<author><name sortKey="Narita, Yugo" sort="Narita, Yugo" uniqKey="Narita Y" first="Yugo" last="Narita">Yugo Narita</name>
</author>
<author><name sortKey="Tomimoto, Hidekazu" sort="Tomimoto, Hidekazu" uniqKey="Tomimoto H" first="Hidekazu" last="Tomimoto">Hidekazu Tomimoto</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="doi">10.1002/mds.23022</idno>
<idno type="RBID">pubmed:20131395</idno>
<idno type="pmid">20131395</idno>
<idno type="wicri:Area/PubMed/Corpus">001977</idno>
<idno type="wicri:Area/PubMed/Curation">001977</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Higher-dose glutathione therapy for Parkinson's disease in Japan: is it really safe?</title>
<author><name sortKey="Naito, Yutaka" sort="Naito, Yutaka" uniqKey="Naito Y" first="Yutaka" last="Naito">Yutaka Naito</name>
</author>
<author><name sortKey="Matsuo, Ko" sort="Matsuo, Ko" uniqKey="Matsuo K" first="Ko" last="Matsuo">Ko Matsuo</name>
</author>
<author><name sortKey="Kokubo, Yasumasa" sort="Kokubo, Yasumasa" uniqKey="Kokubo Y" first="Yasumasa" last="Kokubo">Yasumasa Kokubo</name>
</author>
<author><name sortKey="Narita, Yugo" sort="Narita, Yugo" uniqKey="Narita Y" first="Yugo" last="Narita">Yugo Narita</name>
</author>
<author><name sortKey="Tomimoto, Hidekazu" sort="Tomimoto, Hidekazu" uniqKey="Tomimoto H" first="Hidekazu" last="Tomimoto">Hidekazu Tomimoto</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Antiparkinson Agents (administration & dosage)</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Administration Schedule</term>
<term>Glutathione (administration & dosage)</term>
<term>Glutathione (adverse effects)</term>
<term>Glutathione (therapeutic use)</term>
<term>Humans</term>
<term>Japan</term>
<term>Male</term>
<term>Parkinson Disease (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Glutathione</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Glutathione</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Glutathione</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Japan</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Administration Schedule</term>
<term>Humans</term>
<term>Male</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Japon</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">20131395</PMID>
<DateCreated><Year>2010</Year>
<Month>05</Month>
<Day>12</Day>
</DateCreated>
<DateCompleted><Year>2010</Year>
<Month>08</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>25</Volume>
<Issue>7</Issue>
<PubDate><Year>2010</Year>
<Month>May</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Higher-dose glutathione therapy for Parkinson's disease in Japan: is it really safe?</ArticleTitle>
<Pagination><MedlinePgn>962; author reply 962-3</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.23022</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naito</LastName>
<ForeName>Yutaka</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Matsuo</LastName>
<ForeName>Ko</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kokubo</LastName>
<ForeName>Yasumasa</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Narita</LastName>
<ForeName>Yugo</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tomimoto</LastName>
<ForeName>Hidekazu</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>GAN16C9B8O</RegistryNumber>
<NameOfSubstance UI="D005978">Glutathione</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Mov Disord. 2009 May 15;24(7):979-83</RefSource>
<PMID Version="1">19230029</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004334">Drug Administration Schedule</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005978">Glutathione</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" Type="Geographic" UI="D007564">Japan</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>8</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.23022</ArticleId>
<ArticleId IdType="pubmed">20131395</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001977 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001977 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:20131395 |texte= Higher-dose glutathione therapy for Parkinson's disease in Japan: is it really safe? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:20131395" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |